Vimarsana
Biggest News Aggregation in the World

Page 17 - Murray Kessler News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Murray Kessler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Murray Kessler Today - Breaking & Trending Today

Should Investors Be Watching These Top Health Care Stocks Right Now? - Vimarsana News

Should Investors Be Watching These Top Health Care Stocks Right Now?

Are These Top Health Care Stocks Worth Investing In Now? 4 To Consider The health care industry has and continues to play a crucial role in our world today. Because of this, investors continue to turn towards the top health care stocks on the market. It is not surprising that most would be paying more attention to their overall health amidst these times. No doubt, as we are approaching the one-year mark for the current pandemic, health care remains crucial as ever. The healthcare names we often hear about are the likes of vaccine superstars such as Moderna (NASDAQ: MRNA). Another newcomer in ...

Perrigo sells generic drug business for $1.55 billion - Vimarsana News

Perrigo sells generic drug business for $1.55 billion

Perrigo sells generic drug business for $1.55 billion Nick Manes, Crain's Detroit Business Perrigo Company has sold its generic drug business. The Allegan County, Pa.-based pharmaceutical company, which is domiciled for tax purposes in Ireland, announced Monday morning that it would offload the Generic Rx Pharmaceuticals business to New York-based private investment firm Altaris Capital Partners LLC for a total of $1.55 billion. Perrigo said the deal includes $1.5 billion in cash and that Altaris will assume in excess of $50 million in potential milestone payments related to research and deve...

Perrigo's generics split is back on the docket, thanks to $1.55B Altaris offer - Vimarsana News

Perrigo's generics split is back on the docket, thanks to $1.55B Altaris offer

Perrigo is selling its prescription generics business to Altaris Capital Partners for $1.55 billion. The generics unit, which recently nabbed approval for a copycat version of Teva's ProAir HFA inhaler, will establish itself as a standalone company, investment firm Altaris said. The deal is expected to close by the end of the third quarter.

Perrigo To Sell Its Generic Rx Pharmaceuticals Business - Vimarsana News

Perrigo To Sell Its Generic Rx Pharmaceuticals Business

WASHINGTON (dpa-AFX) - Perrigo Company plc (PRGO) has reached a definitive agreement to sell its Generic Rx Pharmaceuticals business to Altaris Capital Partners, LLC for $1.55 billion, including

PERRIGO CO. PLC (NYSE: PRGO): A Bull Case - Vimarsana News

PERRIGO CO. PLC (NYSE: PRGO): A Bull Case

PERRIGO CO. PLC (NYSE: PRGO): A Bull Case We saw a bullish thesis for pharmaceutical company Perrigo Co. PLC (PRGO) on ValueInvestorsClub which we really liked as it is backed by solid data points. We like VIC because the ideas on their site are generally posted by aspiring analysts who produce quality research. Click here for the full article. Below we summarized the PRGO bullish thesis. Perrigo, an American Irish-registered company founded in 1887, is one of the world’s leading manufacturers of global consumer self-care O-T-C healthcare products. The company sells more O-T-C version produ...